Results 161 to 169 of about 570,495 (169)

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Chest, 2010
BACKGROUND Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts.
G. Lip, R. Nieuwlaat, R. Pisters, D. Lane, H. Crijns   +4 more
semanticscholar   +1 more source

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Journal of the American Medical Association (JAMA), 2001
CONTEXT Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described.
A. Go, E. Hylek, Katherine Phillips, Yuchiao Chang, Lori Henault, Joeseph V. Selby, Daniel E. Singer   +6 more
semanticscholar   +1 more source

Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)

Cardiovascular Electrophysiology, 2022
The last three decades have been characterized by an exponential increase in knowledge and advances in the clinical management of atrial fibrillation.
K. Bizhanov, Kuat Аbzaliyev, A. Baimbetov, A. Sarsenbayeva, Evgeny Lyan   +4 more
semanticscholar   +1 more source

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Annals of Internal Medicine, 2007
Context Thirteen new randomized, controlled trials are available since a 1999 meta-analysis of antithrombotic agents for stroke prevention in patients with atrial fibrillation.
R. Hart, L. Pearce, M. Aguilar
semanticscholar   +1 more source

Autoimmune Atrial Fibrillation or Atrial Fibrillation–Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?

Circulation, 2023
499 The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. Correspondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd
V. Algalarrondo, F. Extramiana
semanticscholar   +1 more source

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

The Lancet, 2014
Christian T Ruff, R. Giugliano, E. Braunwald, Elaine B Hoffman, Naveen Deenadayalu, M. Ezekowitz, A. Camm, Jeffrey I. Weitz, Basil S. Lewis, A. Parkhomenko, T. Yamashita, E. Antman   +11 more
semanticscholar   +1 more source

Apixaban versus Warfarin in Patients with Atrial Fibrillation

, 2012
Shinya Goto
semanticscholar   +1 more source

Postoperative Atrial Fibrillation Begets Atrial Fibrillation.

JACC Clinical Electrophysiology
Jeffrey Yim, Andrew D. Krahn
semanticscholar   +1 more source

Postoperative atrial fibrillation: mechanisms, manifestations and management

Nature Reviews Cardiology, 2019
D. Dobrev, M. Aguilar, J. Heijman, J. Guichard, S. Nattel   +4 more
semanticscholar   +1 more source